HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$0.37
Day range
$0.33 - $0.37
Year range
$0.26 - $1.60
Market cap
56.95M USD
Avg Volume
3.96M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 560.00K | — |
Operating expense | 34.83M | 28.00% |
Net income | -36.70M | -1,492.02% |
Net profit margin | -6.55K | — |
Earnings per share | -0.18 | -1,700.00% |
EBITDA | -34.23M | -26.27% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 134.98M | -4.73% |
Total assets | 178.16M | 2.81% |
Total liabilities | 118.54M | 12.15% |
Total equity | 59.62M | — |
Shares outstanding | 170.55M | — |
Price to book | 1.05 | — |
Return on assets | -44.37% | — |
Return on capital | -55.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -36.70M | -1,492.02% |
Cash from operations | -34.03M | -63.40% |
Cash from investing | -15.93M | -208.88% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -49.80M | -926.30% |
Free cash flow | -21.91M | -95.58% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
143
